ID   CEBPD_RAT               Reviewed;         268 AA.
AC   Q03484;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   29-MAY-2024, entry version 135.
DE   RecName: Full=CCAAT/enhancer-binding protein delta;
DE            Short=C/EBP delta;
DE   AltName: Full=Transcription factor CELF;
GN   Name=Cebpd; Synonyms=Celf;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1714459; DOI=10.1016/s0021-9258(18)98648-5;
RA   Kageyama R., Sasai Y., Nakanishi S.;
RT   "Molecular characterization of transcription factors that bind to the cAMP
RT   responsive region of the substance P precursor gene. cDNA cloning of a
RT   novel C/EBP-related factor.";
RL   J. Biol. Chem. 266:15525-15531(1991).
CC   -!- FUNCTION: Transcription activator that recognizes two different DNA
CC       motifs: the CCAAT homology common to many promoters and the enhanced
CC       core homology common to many enhancers (PubMed:1714459). Important
CC       transcription factor regulating the expression of genes involved in
CC       immune and inflammatory responses. Transcriptional activator that
CC       enhances IL6 transcription alone and as heterodimer with CEBPB (By
CC       similarity). {ECO:0000250|UniProtKB:P49716,
CC       ECO:0000269|PubMed:1714459}.
CC   -!- SUBUNIT: Binds DNA as a homodimer and as a heterodimer. Can form stable
CC       heterodimers with CEBPA, CEBPB and CEBPE. Directly interacts with
CC       SPI1/PU.1; this interaction does not affect DNA-binding properties of
CC       each partner. Interacts with PRDM16. {ECO:0000250|UniProtKB:P49716,
CC       ECO:0000250|UniProtKB:Q00322}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:1714459}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:1714459}.
CC   -!- SIMILARITY: Belongs to the bZIP family. C/EBP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M65149; AAA40913.1; -; mRNA.
DR   PIR; B39429; B39429.
DR   RefSeq; NP_037286.1; NM_013154.2.
DR   AlphaFoldDB; Q03484; -.
DR   SMR; Q03484; -.
DR   STRING; 10116.ENSRNOP00000064025; -.
DR   iPTMnet; Q03484; -.
DR   PhosphoSitePlus; Q03484; -.
DR   PaxDb; 10116-ENSRNOP00000064025; -.
DR   Ensembl; ENSRNOT00000074586.3; ENSRNOP00000064025.1; ENSRNOG00000050869.3.
DR   Ensembl; ENSRNOT00055006271; ENSRNOP00055004791; ENSRNOG00055003933.
DR   Ensembl; ENSRNOT00060004676; ENSRNOP00060003347; ENSRNOG00060002893.
DR   Ensembl; ENSRNOT00065013653; ENSRNOP00065010139; ENSRNOG00065008596.
DR   GeneID; 25695; -.
DR   KEGG; rno:25695; -.
DR   AGR; RGD:2328; -.
DR   CTD; 1052; -.
DR   RGD; 2328; Cebpd.
DR   eggNOG; KOG3119; Eukaryota.
DR   GeneTree; ENSGT00940000163032; -.
DR   HOGENOM; CLU_043327_2_1_1; -.
DR   InParanoid; Q03484; -.
DR   OMA; SMEPANF; -.
DR   OrthoDB; 2959124at2759; -.
DR   PhylomeDB; Q03484; -.
DR   PRO; PR:Q03484; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000050869; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro.
DR   GO; GO:0045444; P:fat cell differentiation; ISO:RGD.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045595; P:regulation of cell differentiation; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd14714; bZIP_CEBPD; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR031106; C/EBP.
DR   InterPro; IPR016468; C/EBP_chordates.
DR   PANTHER; PTHR23334; CCAAT/ENHANCER BINDING PROTEIN; 1.
DR   PANTHER; PTHR23334:SF3; CCAAT_ENHANCER-BINDING PROTEIN DELTA; 1.
DR   Pfam; PF07716; bZIP_2; 1.
DR   PIRSF; PIRSF005879; CCAAT/enhancer-binding; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; DNA-binding; Isopeptide bond; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P49716"
FT   CHAIN           2..268
FT                   /note="CCAAT/enhancer-binding protein delta"
FT                   /id="PRO_0000076623"
FT   DOMAIN          191..254
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          98..132
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          152..223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          195..222
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          226..254
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   COMPBIAS        156..171
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        181..223
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49716"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   268 AA;  28600 MW;  EF12ABA104C7B9F8 CRC64;
     MSAALFSLDS PARGAPWPTE PAAFYEPGRV GKPGRGPEPG DLGEPGSTTP AMYDDESAID
     FSAYIDSMAA VPTLELCHDE IFADLFNSNH KAAGAGSLEL LQGGPTRPPG VGSIARGPLK
     REPDWGDGDA PGSLLPAQVA VCAQTVVSLA AAAQPTPPTS PEPPRGSPGP SLAPGPVREK
     GAGKRGPDRG SPEYRQRRER NNIAVRKSRD KAKRRNQEMQ QKLVELSAEN EKLHQRVEQL
     TRDLASLRQF FKELPSPPFL PPTGTDCR
//
